IL17A and neoplasm: However, MAIT cells, characterized by impaired Th1 cytokine production or increased IL-17 secretion, adopt an immunosuppressive phenotype within the TME, which sustains chronic inflammation and tumor growth, or enhance IL-13 expression, fostering a Th2-skewed and protumor microenvironment (63, 64).